Council of Scientific & Industrial Research (CSIR) Current Affairs - 2020

“SWASTHVAYU”: India creates record developing ventilator in 36 days

The Council of Scientific and Industrial Research (CSIR) NAL (National Aerospace Laboratories), Bengaluru has developed a ventilator called “Swasthvayu”. The ventilator has been designed in a record time of 36 days.

Highlights

The ventilator developed by CSIR is a Non-Invasive BiPAP Ventilator. The ventilator is made of built-in biocompatible coupler and a high efficiency filter. These features make the ventilator help reduce the fear against COVID-19.

About the ventilator

The ventilator includes provisions to connect oxygen concentrator externally. The ventilator has been accredited by NABL.

NABL

NABL is National Accreditation Board for Testing and Calibration Laboratories. It tests and certifies medical devices, laboratories, testing providers. It has Mutual Recognition Arrangement with International Laboratory Accreditation Cooperation and Asia Pacific Laboratory Accreditation Cooperation.

Mutual Recognition Agreements

The Mutual Recognition agreements are agreements under which two or more countries agree on one another assessment. These agreements became common after the formation of World Trade Organization.

Signing of such agreements help in improving trade between the countries.

NMITLI Programme of CSIR to conduct “hmAbs” trial to neutrialize COVID-19

The Council of Scientific and Industrial Research (CSIR) under its New Millennium Indian Technology Leadership Initiative (NMITLI) is to develop human monoclonal antibodies (hmAbs). These antibodies will neutralise COVID-19 virus in patients.

Highlights

The CSIR on one side is fighting hard against COVID-19 through its own researches. On the other side, it is also working and supporting industries and public sector units that are coming up with solutions to COVID-19. One such initiative is developing “hmAbs”.

About the project

The project will generate hmAbs from patients that are in convalescent phase. Convalescent is patients that are recovering from illness. The project also aims to generate hmAbs clones. These clones are expected to neutralize mutated virus.

Israel was first

The monoclonal neutralizing antibodies were first developed by Israel. Till now only polyclonal antibodies have been invented. Israel was the first to isolate monoclonal antibodies.

What are monoclonal antibodies?

If the antibodies are recovered from a single recovered cell, they are called monoclonal antibodies. On the other hand, if they are recovered from multiple cells, they are called polyclonal antibodies.

NMITLI

The NMITLI is the largest PPP (Public-private partnership) model of Research and Development programme in the country. The main aim of the project is to catalyse innovation and technological developments.

Previously, fuel cells based on high temperature proton exchange membrane technology was developed under the NMITLI programme.